-
Biotricity Invites Physicians to Join Shared Revenue Opportunity, Provides Clinics with Remote Devices for Improved Monitoring and Diagnosis
Previously Published to Benzinga: The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga. Ranked as one of the fastest-growing companies in the healthcare sector, Biotricity Inc. (NASDAQ: BTCY) sets out to leave an imprint on all 50 states with its connected, real-time monitoring medtech device. For the last 19 months, Dr. Waqaas Al-Siddiq, CEO, chairman and founder of Biotricity, has led his company to list on a major exchange and expand into 23 different states across the U.S. The company’s flagship device — the Bioflux — is a wearable that gives doctors and cardiologists the ability to monitor and diagnose…
-
Biotricity Continues to Transform the Way We Do Health: Medtech Launches New Biokit Solution, Aims at Personal Health Monitoring
Previously Published to Benzinga: The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga. Biotricity (NASDAQ: BTCY) is reforming the healthcare market as one of the fastest-growing companies in medtech. The company bridges the gap in remote cardiac monitoring, preventive and chronic care management by using the power of IoT (internet of things), wearables, and connected devices. Not only does the company offer real-time, comprehensive monitoring and diagnostic services for cardiac-related healthcare and comorbidities, but its devices are also built with features that can dispatch emergency care services should any anomalies or arrhythmias occur when a device is worn. …
-
Biotricity Reports Q1 Earnings at 290% for FY2022
Previously Published to Benzinga: The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga. Biotricity (NASDAQ: BTCY) has been taking the world of medtech by storm, introducing primary care providers across the country to its remote heart monitoring devices. Always connected, these wearable devices have been giving power back to those suffering from chronic cardiac conditions and simultaneous comorbidities — the simultaneous presence of two or more diseases or medical conditions and often relative of one another. Through remote heart monitoring and diagnostic technologies, doctors can screen their patients from a distance, even alerted to a possible emergency if the…
-
Healthy Hearts and Healthy Wallets: Why one HealthTech Startup is a Must-Invest
Previously published to Benzinga: The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga. Last month, we saw a lot of great startups at the Benzinga Global Small Cap Conference. Many of them screamed, “This is an innovation tech stock you need to buy now!” But given the state of our world at this moment, one startup really stood out. Its key product is the Bioflux and it’s considered the “smallest, most accurate device on the market.” Our Current Problem Heart disease is the leading cause of death in men and women every year in the United States.…
You May Also Like
New Smart Contract Technology, Takyon, Fuels EV and Energy Savings While Growing Clean Energy Infrastructure
BEST TECH STARTUPS IN PROVO, UTAH, RANKED
Groundbreaking Studies to Be Conducted on the Effectiveness of Short and Long-term COVID-19 Therapies Inhibiting the Progression of SARS-CoV-2
